Navigating the New Era of MASLD with Dr. Mazen Noureddin

Join us as we dive deep into Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with a true titan in the field: Dr. Mazen Noureddin.

Dr. Noureddin joins us from the Houston Research Institute and Houston Methodist Hospital to break down the complexities of MASLD diagnosis and the modern care pathways that are redefining hepatology. We explore the current state of pharmacologic management and insights into the Phase 2 clinical trial of Efruxifermin (and learn to pronounce it!).

We have a special guest segment with Maria Mironova, the MASLD Special Interest Group (SIG) leader at AASLD, who shares how the SIG is shaping the future of liver research and education.

Hosts:
Vlad Fomin 
Dilara Hatipoglu
Adam Winters
Alex Vogel

Guest:
Mazen Noureddin

Edited by: 
Taylor Gouterman